Variation in colorectal cancer testing between primary care physicians: a cross-sectional study in Switzerland
To determine the proportion of 50–75-year-old patients who visit a primary care physician’s (PCP) office and were tested for colorectal cancer (CRC) by either colonoscopy within 10 years or fecal occult blood testing (FOBT) within 2 years. To describe the variation in care between PCPs and factors associated with these proportions.
Cross-sectional data collected between April and December 2017. Participants: PCPs reporting for the Swiss Sentinel Surveillance Network. Each PCP collected demographic data and CRC testing status from 40 consecutive patients. Measurements: proportions of patients up to date with CRC screening and method used (colonoscopy/FOBT/Other); variation in the outcome measures between PCPs; association of physician-level factors with main outcomes.
91/129 PCPs collected data from 3451 patients; 45% had been tested for CRC within recommended intervals (41% colonoscopy, 4% FOBT). The proportions of patients tested and testing with colonoscopy versus FOBT varied widely between PCPs. Language region was associated with PCPs’ rate of FOBT prescription.
Less than half of patients who visited PCPs in Switzerland were tested for CRC within recommended intervals. PCPs varied widely in their testing practices.
KeywordsPrimary care Colorectal cancer Screening Practice variation Decision making
This work was supported by the funds from the Swiss National Scientific Foundations National Research Plan 74 (NFP74. 407440_167519). The funder played no role in the design or conduct of the study, in the collection, management, analysis, or interpretation of data, or in the preparation, review, or approval of the manuscript.
Compliance with ethical standards
Conflict of interest
None of the authors identified a conflict of interest for this manuscript.
The ethics committee of the canton of Bern waived ethical approval for the study because of the double irreversible patient-data anonymization process (the FOPH cannot identify the patients, and investigators cannot identify the PCPs), so our study fell outside of the scope of the Swiss Human Research Act (REQ-2017-00,280).
- Auer R, Selby K, Bulliard JL, Nichita C, Dorta G, Ducros C et al (2015) Programme cantonal vaudois de dépistage du cancercolorectal: information et décision partagée. Revue Medicale Suisse 11:2229–2215Google Scholar
- Braun AL, Kässner A, Syrogiannouli L, Selby K, Tal K, Del Giovane C, Bulliard J-L, Auer R, Zwahlen M. Association between colorectal cancer testing and insurance status: evidence from the Swiss Health Interview Surveys 2007 and 2012. In: Abstract FM225. Presented at the 2018 Swiss Society of General Internal Medicine (SSGIM). https://primary-hospital-care.ch/fileadmin/content/Supplements/PHC-Suppl_9.pdf
- Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 348:g2467. https://doi.org/10.1136/bmj.g2467 CrossRefGoogle Scholar
- Federal Statistics Office (2017) Nachhaltige Entwicklung, regionale und internationale Disparitäten/Statistische Grundlagen und ÜbersichtenGoogle Scholar
- Hawley S, Lillie S, Cooper G, Elston Lafata J (2014) Managed care patients’ preferences, physician recommendations, and colon cancer screening. Am J Manag Care 20:555–561Google Scholar
- Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K, International Agency for Research on Cancer Handbook Working G (2018) The IARC perspective on colorectal cancer screening. N Engl J Med https://doi.org/10.1056/nejmsr1714643
- Selby K, Cornuz J, Senn N (2015) Establishment of a representative practice-based research network (PBRN) for the monitoring of primary care in Switzerland. J Am Board Fam Med 28:673–675 https://doi.org/10.3122/jabfm.2015.05.150110
- Selby K, Cornuz J, Gachoud D et al (2016) Training primary care physicians to offer their patients faecal occult blood testing and colonoscopy for colorectal cancer screening on an equal basis: a pilot intervention with before-after and parallel group surveys. BMJ Open 6:e011086. https://doi.org/10.1136/bmjopen-2016-011086 CrossRefGoogle Scholar
- Stock C, Brenner H (2010) Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE) Endoscopy 42:546-556 https://doi.org/10.1055/s-0029-1244127
- USPSTF (2016) screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 315:2564–2575 https://doi.org/10.1001/jama.2016.5989